Published in Cancer Chemother Pharmacol on January 01, 1988
Population pharmacokinetics of thioTEPA and its active metabolite TEPA in patients undergoing high-dose chemotherapy. Br J Clin Pharmacol (2001) 0.80
Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate. Clin Pharmacol Ther (1977) 1.61
Comparison of three methods for estimating environmental tobacco smoke exposure among children aged between 12 and 36 months. Int J Epidemiol (1995) 1.32
Binding of quinidine in sera with different levels of triglycerides, cholesterol, and orosomucoid protein. Biochem Pharmacol (1978) 1.23
Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid. J Antimicrob Chemother (1983) 1.15
Variable binding of propranolol in human serum. Biochem Pharmacol (1979) 1.12
Nicotine in hair of smokers and non-smokers: sampling procedure and gas chromatographic/mass spectrometric analysis. Pharmacol Toxicol (1995) 1.12
Long-term effects of inhaled nicotine. Life Sci (1996) 1.07
Production of discrete changes in dopamine and noradrenaline levels and turnover in various parts of the rat brain following exposure to xylene, ortho-, meta-, and para-xylene, and ethylbenzene. Toxicol Appl Pharmacol (1981) 1.05
Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis. Drugs (1987) 1.02
In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans. Clin Pharmacol Ther (1990) 0.98
Single dose pharmacokinetics of tiaprofenic acid. Effects of food and severe renal insufficiency. Arzneimittelforschung (1985) 0.95
Effect of heparin and fatty acids on the binding of quinidine and warfarin in plasma. Biochem Pharmacol (1977) 0.94
Inhalation kinetics of C8 to C10 1-alkenes and iso-alkanes in the rat after repeated exposures. Pharmacol Toxicol (1993) 0.92
Uptake of nicotine in hair during controlled environmental air exposure to nicotine vapour: evidence for a major contribution of environmental nicotine to the overall nicotine found in hair from smokers and non-smokers. Pharmacol Toxicol (1995) 0.90
Accumulation of nicotine in human hair during long-term controlled exposure to a low concentration of nicotine vapour. Pharmacol Toxicol (1997) 0.87
Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children. Antimicrob Agents Chemother (1991) 0.87
Increased amine turnover in several hypothalamic noradrenaline nerve terminal systems and changes in prolactin secretion in the male rat by exposure to various concentrations of toluene. Neurotoxicology (1983) 0.86
Penetration of ceftazidime into the normal rabbit and human eye. Scand J Infect Dis Suppl (1985) 0.86
Toluene-induced activation of certain hypothalamic and median eminence catecholamine nerve terminal systems of the male rat and its effects on anterior pituitary hormone secretion. Toxicol Lett (1980) 0.84
Toluene and telencephalic dopamine: selective reduction of amine turnover in discrete DA nerve terminal systems of the anterior caudate nucleus by low concentrations of toluene. Toxicol Lett (1982) 0.84
Effect of lifelong nicotine inhalation on bone mass and mechanical properties in female rat femurs. Calcif Tissue Int (1999) 0.83
Changes in rat liver microsomal cytochrome P-450 and enzymatic activities after the inhalation of n-hexane, xylene, methyl ethyl ketone and methylchloroform for four weeks. Scand J Work Environ Health (1981) 0.83
Interindividual differences in hair uptake of air nicotine and significance of cigarette counting for estimation of environmental tobacco smoke exposure. Pharmacol Toxicol (1996) 0.83
Effects of xylene and xylene isomers on cytochrome P-450 and in vitro enzymatic activities in rat liver, kidney and lung. Toxicology (1982) 0.82
Inhibition of P-glycoprotein in Caco-2 cells: effects of herbal remedies frequently used by cancer patients. Xenobiotica (2008) 0.82
Effect of nicotine on the enterochromaffin like cells of the oxyntic mucosa of the rat. Life Sci (1993) 0.82
Pharmacokinetics and tissue penetration of Timentin: a simultaneous study of serum, urine, lymph, suction blister and subcutaneous thread fluid. J Antimicrob Chemother (1986) 0.81
The binding of quinidine to protein fractions of normal human sera. Biochem Pharmacol (1975) 0.81
Differences in the serum protein binding of prazosin in man and rat. Biochem Pharmacol (1984) 0.80
Measurement of HPRT mutations in splenic lymphocytes and haemoglobin adducts in erythrocytes of Lewis rats exposed to ethylene oxide. Mutat Res (1999) 0.80
Pharmacokinetics of intraperitoneally instilled aminophylline, terbutaline and tobramycin in pigs. Acta Anaesthesiol Scand (2007) 0.80
Pharmacokinetics of quinidine related to plasma protein binding in man. Eur J Clin Pharmacol (1979) 0.79
Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma. Cancer Chemother Pharmacol (1987) 0.79
A comparison of the binding and distribution of benzo[a]pyrene in human and rat serum. Toxicology (1987) 0.79
Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency. Eur J Clin Pharmacol (1983) 0.79
Dose dependent induction of rat liver microsomal cytochrome P-450 and microsomal enzymatic activities after inhalation of toluene and dichloromethane. Acta Pharmacol Toxicol (Copenh) (1982) 0.79
Metabolic interaction of n-hexane and methyl ethyl ketone in vitro in a head space rat liver S9 vial equilibration system. Pharmacol Toxicol (1998) 0.79
The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency. Br J Clin Pharmacol (1983) 0.78
Polychlorinated terphenyls: alterations in liver morphology and induction of cytochrome P-450. Toxicology (1986) 0.78
Increased microsomal metabolism of n-hexane in rat kidney and liver after inhalation of isopropanol. Arch Toxicol Suppl (1984) 0.78
Long-term pharmacokinetics of thio-TEPA, TEPA and total alkylating activity following i.v. bolus administration of thio-TEPA in ovarian cancer patients. Cancer Chemother Pharmacol (1990) 0.78
Phthalate esters I: Effects on cytochrome P-450 mediated metabolism in rat liver and lung, serum enzymatic activities and serum protein levels. Arch Toxicol (1982) 0.78
Effects of acrylonitrile on rat liver cytochrome P-450, benzo(a)pyrene metabolism and serum hormone levels. Toxicol Lett (1980) 0.78
The binding of thio-TEPA in human serum and to isolated serum protein fractions. Cancer Chemother Pharmacol (1987) 0.77
Effects of polychlorinated terphenyls and paraffins on rat liver microsomal cytochrome P-450 and in vitro metabolic activities. Arch Toxicol (1981) 0.77
Correlation between changes in enzymatic activities and induction of different forms of rat liver microsomal cytochrome P-450 after phenobarbital-, 3-methylcholanthrene- and 16 alpha-cyanopregnenolone treatment. Acta Pharmacol Toxicol (Copenh) (1980) 0.77
Increased binding of quinidine to serum albumin and lipoproteins in anuric rats. Eur J Pharmacol (1975) 0.77
Short-term exposure of rodents to diesel exhausts: usefulness for studies of genotoxic and immunotoxic effects. Chem Biol Interact (1999) 0.77
[Inactivation of drugs by acetylation]. Tidsskr Nor Laegeforen (1975) 0.76
The penetration of ceftazidime into the inflamed rabbit eye. Scand J Infect Dis (1987) 0.76
Pharmacokinetics of midazolam and alfentanil in outpatient general anesthesia. A study with concomitant thiopentone, flumazenil or placebo administration. Acta Anaesthesiol Scand (1988) 0.76
Pharmacokinetics of ceftazidime in patients with biliary tract disease. Eur J Clin Pharmacol (1986) 0.76
Labetalol in the treatment of hypertension in patients with normal and impaired renal function. Acta Med Scand Suppl (1982) 0.75
The influence of antacid on the absorption of two different sustained-release formulations of theophylline. Br J Clin Pharmacol (1983) 0.75
Serum albumin and lipoproteins as the quinidine binding molecules in normal human sera. Biochem Pharmacol (1976) 0.75
The effect of peritonitis on the transperitoneal transport of cefuroxime in patients on CAPD treatment. Nephrol Dial Transplant (1990) 0.75
Drug metabolizing enzymes in the rat after inhalation of halothane and enflurane. Different pattern of response in liver, kidney and lung and possible implications for toxicity. Br J Anaesth (1983) 0.75
Binding of tiaprofenic acid to human sera and isolated serum proteins. Arzneimittelforschung (1985) 0.75
Self-poisoning with theophylline. The effect of repeated doses oral charcoal on drug elimination. Acta Med Scand (1986) 0.75
Effects of chlorinated paraffins on rat liver microsomal activities and morphology. Importance of the length and the degree of chlorination of the carbon chain. Arch Toxicol (1981) 0.75
Displacement of some basic drugs from human serum proteins by enflurane, halothane and their major metabolites. An in vitro study. Br J Anaesth (1984) 0.75
[Acetazolamide]. Tidsskr Nor Laegeforen (1990) 0.75
Penetration of erythromycin in respiratory tract infections. Acta Otolaryngol Suppl (1984) 0.75
The concentrations of ceftazidime and thiopental in maternal plasma, placental tissue and amniotic fluid in early pregnancy. Acta Obstet Gynecol Scand (1987) 0.75
Steady state pharmacokinetics of tiaprofenic acid in elderly patients. Arzneimittelforschung (1985) 0.75
Single-dose pharmacokinetics of lomefloxacin in patients with normal and impaired renal function. Am J Med (1992) 0.75
Gas chromatographic assay of triethylenethiophosphoramide in serum and urine. J Chromatogr (1985) 0.75
Ceftazidime in patients with impaired renal function. Studies on pharmacokinetics and nephrotoxicity. J Chemother (1989) 0.75
Inhalation of isopropanol: induction of activating and deactivating enzymes in rat kidney and liver. Increased microsomal metabolism of n-hexane. Toxicology (1985) 0.75
Pharmacokinetics and distribution of diazepam and oxazepam in early pregnancy. Acta Obstet Gynecol Scand (1988) 0.75
The influence of salts and differences in protein isolation procedure on the binding of quinidine to human serum albumin. Biochem Pharmacol (1976) 0.75
Long-term therapy with sustained-release theophylline. Pharmatherapeutica (1985) 0.75
Changes in rat liver morphology and metabolic activities after exposure to chlorinated paraffins. Dev Toxicol Environ Sci (1980) 0.75
Pharmacokinetics of verapamil and norverapamil in patients with hypertension: a comparison of oral conventional and sustained release formulations. Pharmacol Toxicol (1988) 0.75
Phthalate esters. II. Effects of inhaled dibutylphthalate on cytochrome P-450 mediated metabolism in rat liver and lung. Arch Toxicol (1984) 0.75
The influence of sustained release theophylline therapy on free fatty acids in serum. Acta Pharmacol Toxicol (Copenh) (1985) 0.75
Biochemical and cytological studies of rat lung after inhalation of methanol vapour. Toxicol Lett (1983) 0.75
[Detection of narcotic drugs in the urine. A 2-year case material from Health Region IV]. Tidsskr Nor Laegeforen (1984) 0.75
Induction of cytochrome P-450 in the rat liver after exposure to xylenes, dose-response relationship and dependence on endocrine factors. Toxicology (1983) 0.75
Enzyme induction in liver, kidney and lung after inhalation of halothane and enflurane. Dev Toxicol Environ Sci (1983) 0.75
Oral intake of a toluene-containing thinner. Effects and headspace gas chromatographic analytical diagnosis. Arch Toxicol Suppl (1985) 0.75
[Comparative study of labetolol and propranolol in patients with untreated hypertension]. Tidsskr Nor Laegeforen (1981) 0.75
Glutathione and glutathione S-transferases in rat liver after inhalation of halothane and enflurane. Toxicol Lett (1984) 0.75
Inhalation of enflurane and halothane at subanesthetic concentrations and effects on circulating serum testosterone, luteinizing hormone and follicle-stimulating hormone in the male rat. Toxicol Lett (1983) 0.75
The evaluation of ceftazidime in the treatment of bacterial infections in eighty seriously ill patients. J Antimicrob Chemother (1983) 0.75
Qualitative alterations of cytochrome P-450 in mouse liver microsomes after administration of acrylamide and methylmethacrylate. Acta Pharmacol Toxicol (Copenh) (1978) 0.75
Single and multiple dose pharmacokinetics of tenoxicam in the elderly. Eur J Clin Pharmacol (1988) 0.75
[Acetazolamide]. Tidsskr Nor Laegeforen (1990) 0.75
Absorption of quinidine from an enteric-coated preparation. Eur J Clin Pharmacol (1979) 0.75
Comparison of the serum and tissue concentrations of cefuroxime from cefuroxime axetil and phenoxymethylpenicillin in patients undergoing tonsillectomy. Int J Clin Pharmacol Res (1991) 0.75
Regio-selectivity of purified forms of rabbit liver microsomal cytochrome P-450 in the metabolism of benzo(a)pyrene, n-hexane and 7-ethoxyresorufin. Acta Pharmacol Toxicol (Copenh) (1981) 0.75
Circulating concentrations of testosterone, luteinizing hormone and follicle stimulating hormone in male rats after inhalation of methanol. Arch Toxicol Suppl (1984) 0.75
Inhalation of butanols: changes in the cytochrome P-450 enzyme system. Arch Toxicol Suppl (1985) 0.75